Oneness Biotech Co (ROCO:4743) Accounts Payable & Accrued Expense : NT$109.3 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Oneness Biotech Co Accounts Payable & Accrued Expense?

Oneness Biotech Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (NT$127.3 Mil) to Dec. 2024 (NT$129.1 Mil) but then declined from Dec. 2024 (NT$129.1 Mil) to Mar. 2025 (NT$109.3 Mil).

Oneness Biotech Co's annual accounts payable & accrued expense declined from Dec. 2022 (NT$188.2 Mil) to Dec. 2023 (NT$146.0 Mil) and declined from Dec. 2023 (NT$146.0 Mil) to Dec. 2024 (NT$129.1 Mil).

Oneness Biotech Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Oneness Biotech Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Accounts Payable & Accrued Expense Chart

Oneness Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

125.33

137.32

188.23

146.02

129.13

Oneness Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															121.80	107.39	127.31	129.13	109.33

Oneness Biotech Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Oneness Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (ROCO:4743) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section. 1, Zhongxiao West Road, No. 66, 35th Floor, Zhongzheng District, Taipei, TWN, 100

Website

https://www.onenessbio.com

Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The company's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, OB318, and others. Along with its subsidiaries, the company operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation segment.

Oneness Biotech Co Headlines

No Headlines